Literature DB >> 24698978

Distinct pathways leading to TDP-43-induced cellular dysfunctions.

Makiko Yamashita1, Takashi Nonaka2, Shinobu Hirai3, Akiko Miwa3, Haruo Okado3, Tetsuaki Arai4, Masato Hosokawa5, Haruhiko Akiyama5, Masato Hasegawa2.   

Abstract

TAR DNA-binding protein of 43 kDa (TDP-43) is the major component protein of inclusions found in brains of patients with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP). However, the molecular mechanisms by which TDP-43 causes neuronal dysfunction and death remain unknown. Here, we report distinct cytotoxic effects of full-length TDP-43 (FL-TDP) and its C-terminal fragment (CTF) in SH-SY5Y cells. When FL-TDP was overexpressed in the cells using a lentiviral system, exogenous TDP-43, like endogenous TDP-43, was expressed mainly in nuclei of cells without any intracellular inclusions. However, these cells showed striking cell death, caspase activation and growth arrest at G2/M phase, indicating that even simple overexpression of TDP-43 induces cellular dysfunctions leading to apoptosis. On the other hand, cells expressing TDP-43 CTF showed cytoplasmic aggregates but without significant cell death, compared with cells expressing FL-TDP. Confocal microscopic analyses revealed that RNA polymerase II (RNA pol II) and several transcription factors, such as specificity protein 1 and cAMP-response-element-binding protein, were co-localized with the aggregates of TDP-43 CTF, suggesting that sequestration of these factors into TDP-43 aggregates caused transcriptional dysregulation. Indeed, accumulation of RNA pol II at TDP-43 inclusions was detected in brains of patients with FTLD-TDP. Furthermore, apoptosis was not observed in affected neurons of FTLD-TDP brains containing phosphorylated and aggregated TDP-43 pathology. Our results suggest that different pathways of TDP-43-induced cellular dysfunction may contribute to the degeneration cascades involved in the onset of ALS and FTLD-TDP.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24698978     DOI: 10.1093/hmg/ddu152

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  15 in total

Review 1.  TDP-43 Prions.

Authors:  Takashi Nonaka; Masato Hasegawa
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 2.  Approaches to Gene Modulation Therapy for ALS.

Authors:  Katharina E Meijboom; Robert H Brown
Journal:  Neurotherapeutics       Date:  2022-09-06       Impact factor: 6.088

3.  Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation.

Authors:  Eiichiro Nagata; Takashi Nonaka; Yusuke Moriya; Natsuko Fujii; Yoshinori Okada; Hideo Tsukamoto; Johbu Itoh; Chisa Okada; Tadayuki Satoh; Tetsuaki Arai; Masato Hasegawa; Shunya Takizawa
Journal:  Mol Neurobiol       Date:  2015-10-06       Impact factor: 5.590

4.  Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral Sclerosis.

Authors:  Katherine S Yanagi; Zhijin Wu; Joshua Amaya; Natalie Chapkis; Amanda M Duffy; Kaitlyn H Hajdarovic; Aaron Held; Arjun D Mathur; Kathryn Russo; Veronica H Ryan; Beatrice L Steinert; Joshua P Whitt; Justin R Fallon; Nicolas L Fawzi; Diane Lipscombe; Robert A Reenan; Kristi A Wharton; Anne C Hart
Journal:  Neuroscience       Date:  2019-01-01       Impact factor: 3.590

Review 5.  Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.

Authors:  Alistair Wood; Yuval Gurfinkel; Nicole Polain; Wesley Lamont; Sarah Lyn Rea
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

6.  Profilin 1 mutants form aggregates that induce accumulation of prion-like TDP-43.

Authors:  Yoshinori Tanaka; Masato Hasegawa
Journal:  Prion       Date:  2016-07-03       Impact factor: 3.931

Review 7.  A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis.

Authors:  E Srinivasan; R Rajasekaran
Journal:  J Mol Neurosci       Date:  2020-05-15       Impact factor: 3.444

8.  TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways.

Authors:  Laura De Conti; Maureen V Akinyi; Ramiro Mendoza-Maldonado; Maurizio Romano; Marco Baralle; Emanuele Buratti
Journal:  Nucleic Acids Res       Date:  2015-08-10       Impact factor: 16.971

9.  Chorea as a clinical feature of the basophilic inclusion body disease subtype of fused-in-sarcoma-associated frontotemporal lobar degeneration.

Authors:  Ito Kawakami; Zen Kobayashi; Tetsuaki Arai; Osamu Yokota; Takashi Nonaka; Naoya Aoki; Kazuhiro Niizato; Kenichi Oshima; Shinji Higashi; Omi Katsuse; Masato Hosokawa; Masato Hasegawa; Haruhiko Akiyama
Journal:  Acta Neuropathol Commun       Date:  2016-04-04       Impact factor: 7.801

10.  Using Tetracysteine-Tagged TDP-43 with a Biarsenical Dye To Monitor Real-Time Trafficking in a Cell Model of Amyotrophic Lateral Sclerosis.

Authors:  Janice S W Ng; Maya A Hanspal; Naunehal S Matharu; Teresa P Barros; Elin K Esbjörner; Mark R Wilson; Justin J Yerbury; Christopher M Dobson; Janet R Kumita
Journal:  Biochemistry       Date:  2019-09-18       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.